Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CREX - US22530J3095 - Common Stock

2.89 USD
+0.02 (+0.7%)
Last: 11/28/2025, 8:21:35 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CREX. CREX was compared to 96 industry peers in the Media industry. CREX has a bad profitability rating. Also its financial health evaluation is rather negative. CREX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CREX was profitable.
In the past year CREX has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -1.94%, CREX perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.19%, CREX is in line with its industry, outperforming 51.04% of the companies in the same industry.
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 43.41%, CREX is in line with its industry, outperforming 53.13% of the companies in the same industry.
In the last couple of years the Gross Margin of CREX has grown nicely.
CREX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CREX has been increased compared to 1 year ago.
Compared to 5 years ago, CREX has more shares outstanding
CREX has a worse debt/assets ratio than last year.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CREX has an Altman-Z score of -0.01. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
CREX has a Altman-Z score of -0.01. This is in the lower half of the industry: CREX underperforms 69.79% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CREX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.68, CREX is in line with its industry, outperforming 53.13% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z -0.01
ROIC/WACCN/A
WACC7.33%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.01 indicates that CREX should not have too much problems paying its short term obligations.
CREX has a Current ratio of 1.01. This is comparable to the rest of the industry: CREX outperforms 42.71% of its industry peers.
CREX has a Quick Ratio of 1.01. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
CREX has a worse Quick ratio (0.93) than 61.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.93
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

The earnings per share for CREX have decreased by 0.00% in the last year.
CREX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.59%.
The Revenue has been growing by 9.98% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 50.60% on average per year.
Based on estimates for the next years, CREX will show a very strong growth in Revenue. The Revenue will grow by 32.68% on average per year.
EPS Next Y131.68%
EPS Next 2Y50.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.13%
Revenue Next 2Y11.12%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.64, which indicates a rather expensive current valuation of CREX.
Compared to the rest of the industry, the Price/Earnings ratio of CREX indicates a somewhat cheap valuation: CREX is cheaper than 69.79% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CREX to the average of the S&P500 Index (26.31), we can say CREX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 32.69, CREX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CREX is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 36.59. CREX is around the same levels.
Industry RankSector Rank
PE 20.64
Fwd PE 32.69
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CREX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.94
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CREX's earnings are expected to grow with 50.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y50.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CREX!.
Industry RankSector Rank
Dividend Yield N/A

CREATIVE REALITIES INC

NASDAQ:CREX (11/28/2025, 8:21:35 PM)

2.89

+0.02 (+0.7%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-12 2026-03-12/bmo
Inst Owners14.87%
Inst Owner Change-23.71%
Ins Owners16.83%
Ins Owner Change22.55%
Market Cap30.40M
Revenue(TTM)50.85M
Net Income(TTM)-1.23M
Analysts84
Price Target7.33 (153.63%)
Short Float %1.38%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)225.73%
Min EPS beat(2)-149.99%
Max EPS beat(2)601.45%
EPS beat(4)2
Avg EPS beat(4)117.54%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)6.23%
Revenue beat(4)3
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)4
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-3.18%
PT rev (1m)8.49%
PT rev (3m)8.49%
EPS NQ rev (1m)-89.69%
EPS NQ rev (3m)-269.75%
EPS NY rev (1m)-14.58%
EPS NY rev (3m)-75.3%
Revenue NQ rev (1m)-15.12%
Revenue NQ rev (3m)-30.79%
Revenue NY rev (1m)-3.83%
Revenue NY rev (3m)-9.53%
Valuation
Industry RankSector Rank
PE 20.64
Fwd PE 32.69
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 1.03
P/tB N/A
EV/EBITDA 15.94
EPS(TTM)0.14
EY4.84%
EPS(NY)0.09
Fwd EY3.06%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS4.58
BVpS2.8
TBVpS-1.78
PEG (NY)0.16
PEG (5Y)N/A
Graham Number2.97
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.41%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 6.52
Cap/Depr 54.53%
Cap/Sales 5.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.93
Altman-Z -0.01
F-Score3
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y131.68%
EPS Next 2Y50.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year-1.13%
Revenue Next 2Y11.12%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-161.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year580.51%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-268.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.91%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to CREX.


What is the valuation status for CREX stock?

ChartMill assigns a valuation rating of 4 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to grow by 131.68% in the next year.